561 filings
Page 3 of 29
4
George Robert E.
27 Dec 23
Moleculin Biotech / Robert E. George ownership change
7:31am
4
Klemp Walter V
27 Dec 23
Moleculin Biotech / WALTER V KLEMP ownership change
7:31am
424B5
MBRX
Moleculin Biotech Inc
22 Dec 23
Prospectus supplement for primary offering
5:00pm
8-K
MBRX
Moleculin Biotech Inc
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
MBRX
Moleculin Biotech Inc
18 Dec 23
Regulation FD Disclosure
8:55am
8-K
MBRX
Moleculin Biotech Inc
11 Dec 23
Regulation FD Disclosure
8:55am
8-K
MBRX
Moleculin Biotech Inc
11 Dec 23
Moleculin Presents Positive Interim Data from Phase 1B/2 Clinical Trial in AML at Meeting with KOL’s in Conjunction with ASH Annual Meeting
8:50am
8-K
MBRX
Moleculin Biotech Inc
20 Nov 23
Regulation FD Disclosure
9:15am
8-K
MBRX
Moleculin Biotech Inc
13 Nov 23
Regulation FD Disclosure
8:30am
8-K
MBRX
Moleculin Biotech Inc
13 Nov 23
Regulation FD Disclosure
8:05am
10-Q
2023 Q3
MBRX
Moleculin Biotech Inc
Quarterly report
13 Nov 23
8:00am
8-K
MBRX
Moleculin Biotech Inc
13 Nov 23
Moleculin Reports Third Quarter 2023 Financial Results
8:00am
8-K
MBRX
Moleculin Biotech Inc
7 Nov 23
Regulation FD Disclosure
8:45am
8-K
MBRX
Moleculin Biotech Inc
6 Nov 23
Regulation FD Disclosure
8:35am
8-K
MBRX
Moleculin Biotech Inc
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
MBRX
Moleculin Biotech Inc
17 Oct 23
Regulation FD Disclosure
9:00am
8-K
MBRX
Moleculin Biotech Inc
6 Oct 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
MBRX
Moleculin Biotech Inc
2 Oct 23
Regulation FD Disclosure
8:40am
8-K
MBRX
Moleculin Biotech Inc
21 Sep 23
Regulation FD Disclosure
8:50am
8-K
MBRX
Moleculin Biotech Inc
18 Sep 23
Moleculin Announces New Positive Independent Report of No Cardiotoxicity in Annamycin
8:40am